Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (2099)	11/6/1997 6:32:00 PM
From: Steve Childs	Read Replies (3) \| Respond to of 23519

I read somewhere (I'll try and find it if needed) that 311 patients in Viagra's Phase 3 clincial trials (out of what, 1200 men?) had no organic dysfunction whatsoever. There were no men in the Muse study with this particular circumstances. All were required to have not had an erection for 90 days, and the average was four years without an erection. I believe all had orgainic dysfunction.

To: Tunica Albuginea who wrote (2099)	11/7/1997 8:08:00 AM
From: BigKNY3	Read Replies (2) \| Respond to of 23519

Tunica <<Judging from the FDA's muzzling of their Niagara Ads it is clear the PFE is exaggerating their claims>> Tunica, I hate to spoil you excitement about this "ad", but it never existed. Is was a "joke" posted by Dr. Jerry on the SI Pfizer Board. Pfizer can not legally promote Viagra to the public or healthcare professionals until the product is approved by the FDA. BigKNY3